BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Birkenkamp K, O'Horo JC, Kashyap R, Kloesel B, Lahr BD, Daniels CE, Nichols FC 3rd, Baddour LM. Empyema management: A cohort study evaluating antimicrobial therapy. J Infect 2016;72:537-43. [PMID: 26987740 DOI: 10.1016/j.jinf.2016.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Sokouti M, Ghojazadeh M, Sokouti M, Sokouti B. Surgical and nonsurgical outcomes for treating a cohort of empyema thoracis patients: A monocenteric retrospective cohort study. Ann Med Surg (Lond) 2017;24:19-24. [PMID: 29062481 DOI: 10.1016/j.amsu.2017.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Sundaralingam A, Banka R, Rahman NM. Management of Pleural Infection. Pulm Ther 2021;7:59-74. [PMID: 33296057 DOI: 10.1007/s41030-020-00140-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Matzkies LM, Raggam RB, Flick H, Rabensteiner J, Feierl G, Hoenigl M, Prattes J. Prognostic and diagnostic potential of suPAR levels in pleural effusion. J Infect 2017;75:465-7. [PMID: 28712936 DOI: 10.1016/j.jinf.2017.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
4 Hata R, Kawanami T, Noguchi S, Fukuda K, Akata K, Yamasaki K, Saito M, Yatera K, Mukae H. Clinical characteristics of patients with bacterial pleuritis in the presence of Streptococcus anginosus group and obligate anaerobes detected by clone library analysis. Clin Respir J 2020;14:267-76. [PMID: 31816139 DOI: 10.1111/crj.13127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Bedawi EO, Hassan M, McCracken D, Rahman NM. Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics. Expert Rev Respir Med 2019;13:337-47. [PMID: 30707629 DOI: 10.1080/17476348.2019.1578212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Bostock IC, Sheikh F, Millington TM, Finley DJ, Phillips JD. Contemporary outcomes of surgical management of complex thoracic infections. J Thorac Dis 2018;10:5421-7. [PMID: 30416790 DOI: 10.21037/jtd.2018.08.43] [Reference Citation Analysis]
7 Yang W, Zhang B, Zhang ZM. Infectious pleural effusion status and treatment progress. J Thorac Dis 2017;9:4690-9. [PMID: 29268539 DOI: 10.21037/jtd.2017.10.96] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
8 Cargill TN, Hassan M, Corcoran JP, Harriss E, Asciak R, Mercer RM, McCracken DJ, Bedawi EO, Rahman NM. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J 2019;54:1900541. [PMID: 31391221 DOI: 10.1183/13993003.00541-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bedawi EO, Hassan M, Rahman NM. Recent developments in the management of pleural infection: A comprehensive review. Clin Respir J 2018;12:2309-20. [PMID: 30005142 DOI: 10.1111/crj.12941] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 Porcel JM, Ferreiro L, Rumi L, Espino-Paisán E, Civit C, Pardina M, Schoenenberger-Arnaiz JA, Valdés L, Bielsa S. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial. Pleura Peritoneum 2020;5:20190027. [PMID: 32934974 DOI: 10.1515/pp-2019-0027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]